Posted inNews and Updates
AstraZeneca, Ionis ATTR-CM Drug Trial Fails Primary Goal
AstraZeneca and Ionis face a setback as their ATTR-CM drug trial misses primary goals. See why analysts believe the market reaction may be an over-reaction.
Posted inNews and Updates
Yesafili Shows Efficacy in Treating Diabetic Macular Edema
New peer-reviewed data confirms the efficacy and safety of Yesafili in treating Diabetic Macular Edema, offering a robust biosimilar option for patients.
Posted inNews and Updates
Amgen Drug Withdrawn Following Data Integrity Concerns
Regulators have ordered the withdrawal of an Amgen drug after evidence of data manipulation, highlighting critical lapses in clinical trial integrity.
Posted inNews and Updates
Wainua Fails Key Heart Disease Trial: What It Means for Care
AstraZeneca and Ionis face a setback after Wainua fails to meet primary endpoints in a recent heart disease trial. Learn the clinical and market implications.
Posted inNews and Updates
Roche Halts Two Huntington’s Disease Drug Trials
Roche has discontinued two late-stage Huntington’s disease drug trials after data failed to show clinical efficacy in lowering toxic huntingtin protein.
Posted inNews and Updates
AstraZeneca and Ionis Halt Eplontersen Heart Trial
AstraZeneca and Ionis end Phase 3 heart disease trial for eplontersen after failing to meet primary endpoints in patients with ATTR-CM.
Posted inNews and Updates
New Stem Cell Therapy Shows Promise for Parkinson’s Disease
A new clinical trial reveals that stem cell-derived dopamine cells are safe and effective for treating Parkinson’s disease symptoms. Learn more here.
Posted inNews and Updates
FDA Clears Investigational New Drug Application for FT839
Fate Therapeutics has received FDA clearance for its FT839 IND application. Learn how this iPSC-derived CAR-NK therapy is shaping the future of oncology.
Posted inNews and Updates
MAIA Biotechnology Reports Positive Phase II Trial Results
MAIA Biotechnology shares positive Phase II results for its novel NSCLC treatment, showing strong efficacy and potential for advanced lung cancer patients.
Posted inNews and Updates
Transforming MS Clinical Trials: A New Immune Focus
Discover how modern clinical trials are shifting focus toward immune-system dynamics to better treat multiple sclerosis and improve long-term patient care.